BUSINESS
No mandatory relabelling of pre-revised GST stock, NPPA offers ease of compliance to industry
The National Pharmaceutical Pricing Authority (NPPA) clarified that companies can continue selling pre-GST stock without re-stickering, provided they ensure price compliance at the retail level through revised price lists and public communication.
BUSINESS
Apollo Hospitals to acquire IFC stake in AHLL for Rs 1,254 crore; announces Rs 573 crore oncology investment in Gurugram
AHLL consists primary care and diagnostics, birthing & women’s Health (Apollo Cradle), ambulatory care centers, dialysis & dental networks.
BUSINESS
Genomics major lllumina bets on India to power affordable innovation amid global headwinds
"India is not just a cost center—it’s becoming a core innovation engine for us," said Ankur Dhingra, Chief Financial Officer of Illumina told Moneycontrol.
BUSINESS
Dr. Reddy's acquires J&J's Stugeron brand for $50.5 million
The acquisition is a strategic move to strengthen Dr. Reddy's Central Nervous System (CNS) portfolio and expand into the anti-vertigo segment.
BUSINESS
GST rate cut to spur broader access and market growth of Indian pharma market
The sector, which recorded an 8.7% value growth in August 2025, is now bracing for a broader transformation in pricing, access, and patient volumes.
BUSINESS
Eye care chain ASG Hospitals accelerates expansion with IPO plans, eyes 700+ centres across India
The company is also preparing for a potential IPO within 18–24 months, as it consolidates its position in tier-2 and tier-3 cities and deepens its footprint in underserved districts.
BUSINESS
GSK working on affordable vaccines for neglected diseases, partnership with India key: Jamila Louahed
Jamila Louahed - VP, Head Global R&D for Therapeutic Vaccines and Belgium R&D Site Head for GSK outlined how the pharma major's innovations are being deployed to tackle diseases like malaria, typhoid, tuberculosis, and Shigella.
BUSINESS
Somerset Indus Capital Partners nears $250 million close for 3rd healthcare fund
The fund, which focuses on expanding healthcare access to underserved tier 2 and 3 cities, has drawn commitments from a diverse mix of institutional investors
BUSINESS
Delhi chemists want 3-month window to clear pharma stock after GST cut
The Retail Distribution Chemist Alliance has sought immediate relief after GST on medicines was reduced to 5% from 12%, creating an inventory crisis for pharmacies holding stock purchased at the higher rate
BUSINESS
Zydus Life arm reports positive phase-3 trial results in rare liver disease, eyes USFDA nod in 2026
The Ahmedabad-based drugmaker plans to file for USFDA approval in the first quarter of 2026, targeting a market projected to reach $10.8 billion by 2026, growing at a CAGR of 36.3%.
BUSINESS
AHPI asks insurers to resume cashless services, ready to review its advisory
"In view of the discussions today, AHPI urged the insurers that they must immediately restore cashless services at its member hospitals, as the disruption is placing an unfair financial and emotional burden on patients," the association said in a statemen
BUSINESS
Delhi nursing home body alleges 'cartelization' of private insurers, seeks inflation-linked hospital tariffs
The Delhi Medical Association Nursing Home Forum (DMANHF) on Thursday filed a formal complaint with the Insurance Regulatory and Development Authority of India (IRDAI), alleging cartel-like behaviour by private insurers acting through the General Insurance Council (GIC).
BUSINESS
Oncology emerges as top revenue and profitability driver for India’s leading hospital chains
Once a niche segment, cancer care is now central to the strategic plans of Max Healthcare, Apollo Hospitals, and Fortis Healthcare, among others, driven by rising incidence, improved diagnostics, and high-complexity treatments that command premium pricing.
BUSINESS
AiMeD warns blanket GST rejig could hurt domestic MedTech, calls for balanced tax structure
The Association of Indian Medical Device Industry (AiMeD) said that while reducing GST to 5% on high-value equipment like electronics and implants could improve affordability and market reach, applying the same rate to low-margin consumables such as syringes, catheters, and IV sets would worsen the inverted duty structure—where inputs are taxed at 18% and outputs at 5% or 12% leading to margin compression and supply risks.
BUSINESS
GSK re-enters India’s oncology market with Jemperli and Zejula, unveils tiered pricing and patient support program
Bhushan Akshikar, Managing Director of GSK India, said the company is committed to making these therapies accessible through a tiered pricing strategy and a comprehensive patient support program branded Phoenix.
BUSINESS
Apollo Hospitals MD Suneeta Reddy sells 1.3% stake to cut debt
MD Suneeta Reddy has sold a 1.3 percent stake in the company through a block deal, raising approximately Rs 1,489 crore
BUSINESS
Abbott launches next gen CGM device FreeStyle Libre 2 Plus in India
The new sensor transmits glucose data directly to a smartphone without requiring manual scans, and can be worn for up to 15 days.
BUSINESS
Medical devices firm Biorad Medisys open to strategic investors to fund expansion and R&D push
Pune-based Biorad Medisys last year raised Rs 350 crore through optionally convertible debentures (OCDs) from Kotak Strategic Situations India Fund II for repaying previous debt, fund capex and expand footprint in both domestic and international markets.
BUSINESS
Fortis Healthcare expands UP footprint with 550-bed hospital in Lucknow
The facility, to be built near Gomti Nagar by the Ekana Group, will be positioned as a Centre of Excellence for tertiary care services.
BUSINESS
Advent-backed CDMO firm Cohance scouts for western API assets to meet demand and hedge against tariffs
Cohance already supplies API intermediates from India but sees strategic value in owning Western manufacturing capabilities.
BUSINESS
Accurius eyes $7 million fund raise for novel anti-cancer therapy, to leverage India for clinical trials & manufacturing
Srivatsan said the company is exploring trial sites in India, Australia, and the US, with a pre-IND (Investigational New Drug) meeting with the USFDA expected within six months of closing the round. Phase 1 trials will enroll 15–30 patients with lung-localized cancers, including non-small cell lung cancer and metastatic tumors.
BUSINESS
Amansa invests Rs 250 crore in Rubicon Research ahead of IPO
The deal involved the transfer of 5.16 million equity shares by General Atlantic Singapore RR Pte. Ltd to Amansa at Rs 484.47 a share
BUSINESS
Max Healthcare doubles down on hospital expansion, plans new facility in Gurugram
The company plans to add 1,500 beds by the end of the year, as part of aggressive expansion strategy to drive higher-margin growth
BUSINESS
Lilly launches Mounjaro KwikPen in India, matches vial pricing for diabetes and obesity
Each KwikPen contains four doses, designed for single-patient use, and is priced between Rs14,000 and Rs 27,500 per month depending on strength.
